Semaglutide Exports Go Ahead, India Sales Stay Frozen
Refusing to interfere with its earlier order, the Delhi High Court has allowed Dr Reddy’s Laboratories to keep manufacturing and exporting a semaglutide-based Ozempic-like drug to non-patent jurisdictions. Commercial sales in India remain barred while Novo Nordisk’s infringement and validity claims over patent IN 697 are fought out at trial.
Dr Reddy’s Buys Its Way Into Immutep’s Immuno-Oncology Play
Dr Reddy’s Laboratories has inked a licensing deal to market an Immutep cancer therapy in India, deepening its oncology portfolio via in-licensing rather than homegrown R&D. The pact reflects a broader Indian trend of securing cutting-edge immuno-oncology drugs through regional rights, co-development options and reliance on global trial data.
Fake Gavaskar Ads Put Big Tech on the Back Foot
Responding to a plea by Sunil Gavaskar, the Delhi High Court has directed Google, Meta and X to act on complaints over fake ads and misleading content misusing his name and photos. The court pressed the platforms on their takedown processes and duties where personality rights and impersonation are involved.
Delhi HC Orders ‘Mask’ Film Makers to Drop Saregama-Owned ‘Naguva Nayana’ Song or Pay ₹30 Lakh
In a copyright clash with Saregama, the Delhi High Court has told the makers of Kannada film Mask to either stop using classic track “Naguva Nayana” or deposit ₹30 lakh. With no licence in place, the court found prima facie infringement and linked any continued use to a security deposit.
Salman Khan Draws a Legal Line Around His Persona
Salman Khan has moved the Delhi High Court seeking a blanket shield over his personality rights, targeting websites, apps and e-commerce players allegedly cashing in on his name, image and likeness. The petition flags unauthorised merchandise, AI-generated content and misleading promotions that suggest endorsements he has never given.
Is ‘Pudin Hara’ Really Made Up? Court to Test the Claim
The Delhi High Court will now decide whether Dabur’s “Pudin Hara” for ayurvedic digestive remedies is a coined mark or a descriptive term for mint-based relief. The case turns on acquired distinctiveness and consumer association, and could influence protection for long-used brands that echo ingredients or therapeutic effects.
FedEx Fights Financial Copycats in Bombay HC
FedEx has won interim relief from the Bombay High Court against financial companies using marks and logos close to its famous brand. Finding a clear likelihood of confusion and false association with the global logistics giant, the court temporarily restrained the defendants from using deceptively similar branding in their services.
Prior User Wins: ‘Elante’ Registrations Wiped Off the Register
Backing the first adopter, the Delhi High Court has ordered the “Elante” trademarks removed from the register after finding the petitioner to be the prior user. Reaffirming that prior user rights trump later registration, the court held that subsequent proprietors cannot commandeer goodwill built through earlier continuous commercial use.
Flipkart Told to Clean House on Counterfeit S Chand Books
The Delhi High Court has directed Flipkart to delist counterfeit S Chand textbooks from its marketplace. Once notified of specific infringing listings, the court held, an intermediary must act or risk contributory liability. The order tightens expectations on platforms dealing in pirated educational content and counterfeit exam material.
DPS Crest Still Counts: Bhiwadi School Stripped of Name and Logo
In a win for the Delhi Public School Society, the Delhi High Court has restrained a Bhiwadi school from using the DPS name, crest or logo without authorisation. Citing the society’s extensive goodwill and network, the court found clear trademark infringement and passing off in the education sector.
Pawan Kalyan’s Face Is Not Free Content, Court Signals
Acting on a suit by Andhra Pradesh Deputy Chief Minister and actor Pawan Kalyan, the Delhi High Court has asked Meta, Google and X to act on complaints over unauthorised use of his name and likeness. The action targets social-media intermediaries, e-commerce platforms and others trading off his persona.
India Floats Royalty Meter for AI Training on Copyrighted Content
India has proposed a regime that would force AI developers, including OpenAI and Google, to pay royalties when training models on copyrighted works. A central licensing and payment mechanism is being explored, signalling tougher scrutiny of large-scale scraping, dataset creation and model-training practices that rely on publisher and creator content.
Disney Accuses Google’s AI of Raiding the Magic Kingdom
Disney has fired a cease-and-desist notice at Google, alleging “massive” copyright infringement by its AI systems through training on and generating outputs featuring Disney characters and stories without permission. The move escalates entertainment-industry pressure on big tech to strike explicit licensing deals for using blockbuster catalogues in AI.
US startup seeks to reclaim ‘Twitter’ trademarks abandoned by X
A US startup has asked regulators to hand it the “Twitter” trademarks it says were abandoned when Elon Musk rebranded the platform to X. Leaning on non-use and abandonment arguments, the bid tests how far radical rebranding can leave heritage marks vulnerable to opportunistic claims by new players.
Hendrix Masters Back in the Spotlight in UK Rights Fight
Jimi Hendrix’s classic albums are at the centre of a UK copyright battle involving Sony Music, as parties clash over ownership and licensing of the recordings. The dispute revisits decades-old contracts and control of the catalogue, highlighting continuing fault lines around how legacy artists’ works are monetised in the streaming era.
Kelun’s Cancer Asset Crosses Borders in Crescent Licensing Deal
China’s Kelun Biotech has licensed a cancer treatment to Crescent Biopharma, handing over territorial rights in a cross-border deal that extends the drug’s commercial reach. The agreement underlines sustained global appetite for oncology assets, with partners trading milestones, data and market access to accelerate development and regional launches.
